GGrantIndex
← Search

PHASE II TRIAL OF MOXIFLOXACIN FOR TB

$64,221R01FY2007FDFDA

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

View original record on NIH RePORTER →